Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NRG Oncology
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Mayo Clinic
Jonsson Comprehensive Cancer Center
City of Hope Medical Center
City of Hope Medical Center
University of Michigan Rogel Cancer Center
University of California, San Francisco
Jonsson Comprehensive Cancer Center
Osel, Inc.